Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
Plos One
|
September 15, 2015
Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers
Nicky D'Haene, Marie Le Mercier, Nancy De Nève, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab
Charlotte Mauclet, Fabrice Duplaquet, Lionel Pirard, et al.
The Oncologist
|
March 30, 2023
A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas
Anne Demols, Laureen Rocq, Luis Perez-Casanova, et al.
Virchows Archiv : an International Journal of Pathology
|
September 11, 2020
Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial
Koen De Winne, Laure Sorber, Suzan Lambin, et al.
Diagnostic Pathology
|
December 13, 2021
Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report
Camille Verocq, Marie-Lucie Racu, Dominique Bafort, et al.
Acta Neuropathologica Communications
|
August 11, 2020
Clinical, radiological and molecular characterization of intramedullary astrocytomas
Laetitia Lebrun, Barbara Meléndez, Oriane Blanchard, et al.
BJS Open
|
November 27, 2024
Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: retrospective study
Julie Navez, Martina Pezzullo, Christelle Bouchart, et al.
Molecular and Clinical Oncology
|
November 18, 2021
Immunohistochemistry as an accurate tool for the assessment of <i>BRAF V600E</i> and <i>TP53</i> mutations in primary and metastatic melanoma
Stefan Rusu, Camille Verocq, Anne Laure Trepant, et al.
Cells
|
July 6, 2023
Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response
Rebekah Crake, Imène Gasmi, Jordan Dehaye, et al.
Neuro-Oncology Advances
|
July 10, 2020
TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors
Diana Cantero, Manuela Mollejo, Juan M Sepúlveda, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
Plos One
|
September 15, 2015
Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers
Nicky D'Haene, Marie Le Mercier, Nancy De Nève, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab
Charlotte Mauclet, Fabrice Duplaquet, Lionel Pirard, et al.
The Oncologist
|
March 30, 2023
A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas
Anne Demols, Laureen Rocq, Luis Perez-Casanova, et al.
Virchows Archiv : an International Journal of Pathology
|
September 11, 2020
Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial
Koen De Winne, Laure Sorber, Suzan Lambin, et al.
Diagnostic Pathology
|
December 13, 2021
Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report
Camille Verocq, Marie-Lucie Racu, Dominique Bafort, et al.
Acta Neuropathologica Communications
|
August 11, 2020
Clinical, radiological and molecular characterization of intramedullary astrocytomas
Laetitia Lebrun, Barbara Meléndez, Oriane Blanchard, et al.
BJS Open
|
November 27, 2024
Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: retrospective study
Julie Navez, Martina Pezzullo, Christelle Bouchart, et al.
Molecular and Clinical Oncology
|
November 18, 2021
Immunohistochemistry as an accurate tool for the assessment of <i>BRAF V600E</i> and <i>TP53</i> mutations in primary and metastatic melanoma
Stefan Rusu, Camille Verocq, Anne Laure Trepant, et al.
Cells
|
July 6, 2023
Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response
Rebekah Crake, Imène Gasmi, Jordan Dehaye, et al.
Neuro-Oncology Advances
|
July 10, 2020
TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors
Diana Cantero, Manuela Mollejo, Juan M Sepúlveda, et al.
Page
of 9